SHINE Technologies: $240 Million Raised For Nuclear Fusion And Medical Isotope Expansion
By Amit Chowdhry ● Feb 26, 2026
SHINE Technologies, a nuclear fusion company, announced it has raised $240 million in equity funding and appointed Dr. Patrick Soon-Shiong, M.D., Executive Chairman of ImmunityBio and founder of NantWorks, to its Board of Directors. The round was led by NantWorks, with participation from Fidelity Management & Research Company, Sumitomo Corporation of Americas, Pelican Energy Partners, Deerfield Management, Oaktree Capital Management, and other existing investors.